The Claim
Selenium supplementation at a dosage of 100–300 μg/day for a duration of 6 months is associated with a reduction in thyrotrophic hormone receptor antibody (TRAb) levels in adults with Graves' disease who are receiving antithyroid medication, but this reduction is not sustained at 9 months.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking selenium supplements daily at 100–300 micrograms for six months may lower levels of antibodies targeting the thyroid-stimulating hormone receptor in adults with Graves' disease who are on antithyroid drugs, but this reduction does not last beyond nine months.
See the scientific wording
Selenium supplementation at 100–300 μg/day for 6 months is associated with a reduction in thyrotrophic hormone receptor antibody (TRAb) levels in adults with Graves' disease on antithyroid medication, but this effect is not maintained at 9 months.
What the research says
1 studyStudy: Effects of Selenium Supplementation on Graves' Disease: A Systematic Review and Meta-Analysis
This study found that taking selenium pills for 6 months helped lower a specific antibody linked to Graves' disease, but after 9 months, that benefit went away — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.